PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
18-Jul-2022 Aegis Sciences Corporation Launches Key Opinion Leadership Series With First Panel on Designer Drugs Businesswire
18-Jul-2022 Market Growth Opportunities in AI for Drug Target Discovery and Validation: Advancements in Deep Learning will Enable Faster and More Efficient Novel Target Discovery. - ResearchAndMarkets.com Businesswire
18-Jul-2022 Global Contraceptives Market to 2029 - Featuring Reckitt Benckiser, Pfizer and Mayer Laboratories Among Others - ResearchAndMarkets.com Businesswire
18-Jul-2022 Johnson & Johnson’s Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022 Businesswire
18-Jul-2022 BlackRock and QLS Advisors Partner Through BlackRock Systematic to Invest in Biomedical Innovation Businesswire
18-Jul-2022 n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research Businesswire
18-Jul-2022 Global Astaxanthin Market Trajectory & Analytics, 2020-2022 & 2026 - ResearchAndMarkets.com Businesswire
18-Jul-2022 NI Showcases Satellite Link Emulation in Cooperation With Ansys Businesswire
18-Jul-2022 Q2 Update by PQE Group: Two Acquisitions’ Announcements With United Pharma Technologies Inc. & Quintian Pharma, and New Two Offices Businesswire
18-Jul-2022 Middle East and Africa In-Vitro Diagnostics (IVD) Market Research Report 2022 - ResearchAndMarkets.com Businesswire
18-Jul-2022 MAIA Biotechnology Doses First Patient With THIO in Phase 2 Trial (THIO-101) for Non-Small Cell Lung Cancer Businesswire
18-Jul-2022 MEI Pharma and Kyowa Kirin Announce Publication in The Lancet Oncology of Data from Phase 1b Clinical Study of Zandelisib in Patients with Relapsed or Refractory B-cell Malignancy Businesswire
18-Jul-2022 Mycovia Pharmaceuticals Announces U.S. Availability of VIVJOA™ (oteseconazole) Capsules, the First and Only FDA-Approved Medication for Recurrent Vulvovaginal Candidiasis (Chronic Yeast Infection) Businesswire
18-Jul-2022 Alzamend Neuro Receives Positive Pre-IND Response from FDA for AL001 Treatment of Bipolar Disorder, Major Depressive Disorder and Post-Traumatic Stress Disorder Businesswire
18-Jul-2022 The Worldwide Digital Pen Industry is Expected to Reach $6.29 Billion by 2030 - ResearchAndMarkets.com Businesswire
18-Jul-2022 Outlook on the Formulation Development Outsourcing Global Market to 2030 - Featuring Intertek, Recipharm and Lonza Among Others - ResearchAndMarkets.com Businesswire
18-Jul-2022 Sesen Bio Announces Strategic Decision to Pause Clinical Development of Vicineum™ in the US Businesswire
18-Jul-2022 Global Calendered Polyvinyl Chloride Flexible Films Market (2022 to 2030) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com Businesswire
18-Jul-2022 Insights on the Medical Ceramics Global Market to 2027 - by Type, Application, End-user and Region - ResearchAndMarkets.com Businesswire
18-Jul-2022 Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief Regulatory Officer Businesswire